Pharma Synth Formulations Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.00 Cr
- Satisfied Charges ₹ 24.03 Cr
- Revenue Growth 0.75%
- Profit Growth 25.43%
- Ebitda -1.17%
- Net Worth 11.97%
- Total Assets 15.77%
About Pharma Synth Formulations
Pharma Synth Formulations Limited (PSFL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 November 1993 and has a history of 31 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹18.00 Cr. The company has closed loans amounting to ₹24.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Phoolwati Jain, Arvind Gupta, and Ramesh Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1993PLC056231
- Company No.
056231
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Nov 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Pharma Synth Formulations Limited offer?
Pharma Synth Formulations Limited offers a wide range of products and services, including Common Disease Medicines, Oral Care Products, Healthcare Products & Aids, Health Drinks, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics.
Pharma Synth Formulations Limited
Explore comprehensive data for Pharma Synth Formulations Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Pharma Synth Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Phoolwati Jain  | Director | 08-Mar-1994 | Current |
| Arvind Gupta | Director | 26-Nov-1993 | Current |
| Ramesh Jain | Director | 26-Nov-1993 | Current |
Financial Performance of Pharma Synth Formulations.
Pharma Synth Formulations Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.75% increase. The company also saw a substantial improvement in profitability, with a 25.43% increase in profit. The company's net worth Soared by an impressive increase of 11.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Synth Formulations?
In 2024, Pharma Synth Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
B L D Exports Private LimitedPhoolwati Jain is a mutual person
Charges (Loans)
Open Charges
₹180.00 M
Satisfied Charges
₹240.32 M
Charges Breakdown by Lending Institutions
- Sidbi : 18.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Sidbi | ₹2.00 Cr | Open |
| 13 Sep 2024 | Sidbi | ₹8.00 Cr | Open |
| 13 Sep 2024 | Sidbi | ₹8.00 Cr | Open |
| 20 Jan 2023 | Sidbi | ₹16.00 Cr | Satisfied |
| 28 Mar 2022 | Sidbi | ₹2.00 Cr | Satisfied |
How Many Employees Work at Pharma Synth Formulations?
Pharma Synth Formulations has a workforce of 223 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Synth Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Synth Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Pharma Synth Formulations
Recent activity within the organization
- Annual General Meeting
Pharma Synth Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge registered on 20 Jan 2023 via Charge ID 100674524 with Sidbi was fully satisfied on 24 Sep 2024.
- Charges
A charge registered on 28 Mar 2022 via Charge ID 100551116 with Sidbi was fully satisfied on 24 Sep 2024.
- Charges
A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100978996 was registered on 13 Sep 2024.
- Charges
A charge with Sidbi amounted to Rs. 80.00 M with Charge ID 100979003 was registered on 13 Sep 2024.
- Charges
A charge with Sidbi amounted to Rs. 80.00 M with Charge ID 100979051 was registered on 13 Sep 2024.
Frequently asked questions
What is the Incorporation or founding date of Pharma Synth Formulations Limited?
Pharma Synth Formulations Limited was incorporated on 26 Nov 1993.
What is authorized share capital and paid-up capital of Pharma Synth Formulations Limited?
The authorized share capital of Pharma Synth Formulations Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Pharma Synth Formulations Limited?
Currently 3 directors are associated with Pharma Synth Formulations Limited.
- Phoolwati Jain
- Arvind Kumar Gupta
- Ramesh Chand Jain
What is the registered address of Pharma Synth Formulations Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Pharma Synth Formulations Limited is A - 10/15Jhilmil Industrial Area India, Delhi, 110095.
What is the corporate identification number (CIN) and company number of Pharma Synth Formulations Limited?
The corporate identification number (CIN) of Pharma Synth Formulations Limited is U74899DL1993PLC056231 and the company number is 056231 as per Ministry of Corporate Affairs (MCA).
What is the official website of Pharma Synth Formulations Limited?
The Official website of Pharma Synth Formulations Limited is https://www.pharmasynth.in
What has been the recent revenue trend for Pharma Synth Formulations Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Pharma Synth Formulations Limited has risen by 0.75%.
How many employees does Pharma Synth Formulations Limited currently have?
As Per 2024 financial reports, 223 employees are currently employed by Pharma Synth Formulations Limited.
What change has been observed in the net worth of Pharma Synth Formulations Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Pharma Synth Formulations Limited has experienced an upsurge of 11.97%.
What are the total open charges for Pharma Synth Formulations Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Pharma Synth Formulations Limited amount to ₹ 18.00 Cr.
When was the last Balance Sheet of Pharma Synth Formulations Limited filed with the ROC?
The most recent Balance Sheet for Pharma Synth Formulations Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records